CAMBRIDGE, Mass. and PHILADELPHIA, PA — Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information and commercialization platform, and Coriell Life Sciences, Inc., an innovative provider of clinical genetic reporting solutions, announced today a partnership and platform integration designed to create a seamless ecosystem for sample and workflow management, genetic data interpretation, and external client […]

Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]

— Aims to accelerate manufacturing of new treatments for broad range of serious diseases — Underscores MilliporeSigma as a leading contract manufacturing organization and commercial provider of viral vectors for gene therapy BURLINGTON, Mass. — MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for […]

WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]

Innovative enterprise platform for clinical cross-omics now also accessible via high-performance cloud computing services Microsoft Azure and Amazon Web Services Basel, Switzerland Genedata, a leading provider of advanced software solutions for biopharmaceutical research and development (R&D), today announced that Genedata ProfilerTM, its leading enterprise software platform for omics-based profiling of patients in translational and clinical […]

RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is intended for prognostic use […]

Potato pangenome research drives cooperation between international public and private sectors Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, is working with a team of researchers from Wageningen University & Research (WUR) in the Netherlands and leading commercial partners to create multi-genome mapping of commercial food potatoes. Potatoes are the fourth […]

Powervar’s Security Plus UPS Showcased at SCIEX Customer Demonstration Facility WAUKEGAN, IL – AMETEK Powervar, a leading supplier of power conditioning and uninterruptible power supply (UPS) solutions, is proud to announce that its Security Plus UPS system has been approved for use with SCIEX mass spectrometer instruments. SCIEX, is a global leader in life science analytical technologies. As part of […]

Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY - Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]

BC Platforms, a world leader in genomic data management and analysis solutions, announces co-operation with FinnGen program. FinnGen is a unique study that has been launched in Finland. Program will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by […]